Collection and Handling of Blood Specimens for Peptidomics

Methods in Molecular Biology

Volumn 728, Issue , 2011, Pages 151-159

  Tammen, Harald ^a   Hess, Rüdiger ^b  

^a PXBioVisioN GmbH   (Germany)

^b NONE

Author keywords

Blood; HUPO; Peptidomics; Plasma; Pre analytical variables; Serum; Specimen

Indexed keywords

PEPTIDE;

ARTICLE; BLOOD; BLOOD SAMPLING; CENTRIFUGATION; HUMAN; METABOLISM; METHODOLOGY; PHLEBOTOMY; PROTEOMICS; THROMBOCYTE;

BLOOD PLATELETS; BLOOD SPECIMEN COLLECTION; CENTRIFUGATION; HUMANS; PEPTIDES; PHLEBOTOMY; PROTEOMICS;

EID: 79960149944     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-068-3_9     Document Type: Chapter

References (40)

1. Schrader, M. and Schulz-Knappe, P. (2001) Peptidomics technologies for human body fluids. Trends Biotechnol. 19, 55–60
2. Baggerman, G., Verleyen, P., Clynen, E., et al. (2004) Peptidomics. J Chromatogr.B Analyt. Technol.Biomed.Life Sci. 803, 3–16
3. Soloviev, M. and Finch, P. (2005) Peptidomics, current status. J Chromatogr.B Analyt.Technol. Biomed.Life Sci. 815, 11–24
4. Tammen, H., Zucht, H. D., and Budde, P. (2007) Oncopeptidomics-A commentary on opportunities and limitations. Cancer Lett. 249, 80–86
5. Schrader, M. and Schulz-Knappe, P. (2001) Peptidomics technologies for human body fluids. Trends Biotechnol. 19, S55–S60
6. Schulz-Knappe, P., Zucht, H. D., Heine, G., et al. (2001) Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb.Chem High Throughput Screen. 4, 207–217
7. Pierson, J., Norris, J. L., Aerni, H. R., et al. (2004) Molecular profiling of experimental Parkinson’s disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome.Res. 3, 289–295
8. Pasinetti, G. M., Ungar, L. H., Lange, D. J., et al. (2006) Identification of potential CSF biomarkers in ALS. Neurology 66, 1218–1222
9. Sasaki, K., Sato, K., Akiyama, Y., et al. (2002) Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res. 62, 4894–4898
10. Zhang, X., Wei, D., Yap, Y., et al. (2007) Mass spectrometry-based “omics” technologies in cancer diagnostics. Mass Spectrom Rev. 26, 403–431
11. Lopez, M. F., Mikulskis, A., Kuzdzal, S., et al. (2007) A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound Peptide biomarker candidates in ovarian cancer samples. Clin Chem. 53, 1067–1074
12. Overall, C. M. and Blobel, C. P. (2007) In search of partners: linking extracellular proteases to substrates. Nat.Rev Mol Cell Biol. 8, 245–257
13. Rai, A. J. and Vitzthum, F. (2006) Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev Proteomics 3, 409–426
14. Omenn, G. S., States, D. J., Adamski, M., et al. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 5, 3226–3245
15. Rai, A. J., Gelfand, C. A., Haywood, B. C., et al. (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262–3277
16. Hsieh, S. Y., Chen, R. K., Pan, Y. H., and Lee, H. L. (2006) Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 6, 3189–3198
17. Mollnes, T. E., Garred, P., and Bergseth, G. (1988) Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin.Exp.Immunol. 73, 484–488
18. Tammen, H., Schulte, I., Hess, R., et al. (2005) Peptidomic Analysis of Human Blood Specimens: Comparison between Plasma Specimens and Serum by Differential Peptide Display. Proteomics 5
19. Koomen, J. M., Li, D., Xiao, L. C., et al. (2005) Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res. 4, 972–981
20. Evans, M. J., Livesey, J. H., Ellis, M. J., and Yandle, T. G. (2001) Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem. 34, 107–112
21. Guder W.G., N. S. W. H. Z. B. (2003) Samples: From the Patient to the Laboratory. Wiley-VCH 3rd Edition
22. Tammen, H., Schulte, I., Hess, R., et al. (2005) Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb Chem High Throughput Screen 8, 725–733
23. Villanueva, J., Shaffer, D. R., Philip, J., et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 116, 271–284
24. Liotta, L. A. and Petricoin, E. F. (2006) Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest. 116, 26–30
25. Banfi, G., Salvagno, G. L., and Lippi, G. (2007) The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin.Chem.Lab Med. 45, 565–576
26. Landi, M. T. and Caporaso, N. (1997) Sample collection, processing and storage. IARC Sci Publ. 223–236
27. Holland, N. T., Smith, M. T., Eskenazi, B., and Bastaki, M. (2003) Biological sample collection and processing for molecular epidemi-ological studies. Mutat.Res. 543, 217–234
28. Lundblad R.L. (2004) Considerations for the Use of Blood Plasma and Serum for Proteomic Analysis. The Internet Journal of Genomics and Proteomics
29. Pfeifer, P. H., Brems, J. J., Brunson, M., and Hugli, T. E. (2000) Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study. Immunopharmacology 46, 163–174
30. Plebani, M. and Carraro, P. (1997) Mistakes in a stat laboratory: types and frequency. Clin Chem. 43, 1348–1351
31. Burtis, C. A. A. E. R. (2001) Fundamentals of Clinical Chemistry W.B. Saunders Company.
32. Winkel, P., Statland, B. E., and Bokelund, H. (1975) The effects of time of venipuncture on variation of serum constituents. Consideration of within-day and day-to-day changes in a group of healthy young men. Am.J.Clin. Pathol. 64, 433–447
33. Favaloro, E. J., Soltani, S., and McDonald, J. (2004) Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol. 122, 686–692
34. Heins, M., Heil, W., and Withold, W. (1995) Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes. Eur.J.Clin.Chem.Clin.Biochem. 33, 231–238
35. Mustard, J. F., Kinlough-Rathbone, R. L., and Packham, M. A. (1989) Isolation of human platelets from plasma by centrifugation and washing. Methods Enzymol. 169, 3–11
36. Schuchard, M. D., Mehigh, R. J., Cockrill, S. L., et al. (2005) Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry. Biotechniques 39, 239–247
37. Jeffrey D. Hulmes, Deidra Bethea, Keith Ho, Shu-Pang Huang, Deborah L. Ricci, Gregory J. Opiteck, and Stanley A. Hefta (2004) An Investigation of Plasma Collection, Stabilization, and Storage Procedures for Proteomic Analysis of Clinical Samples Humana Press.
38. Balkan, B., Kwasnik, L., Miserendino, R., et al. (1999) Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 42, 1324–1331
39. Lambeir, A. M., Durinx, C., Scharpe, S., and De, M., I. (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev.Clin.Lab Sci. 40, 209–294
40. Theodorakis, M. J., Carlson, O., Muller, D. C., and Egan, J. M. (2004) Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 27, 1692–1698